Sex-related differences in antinociception and tolerance development following chronic intravenous infusion of morphine in the rat: Modulatory role of testosterone via morphine clearance

Journal of Pharmacology and Experimental Therapeutics

Volumn 297, Issue 1, 2001, Pages 446-457

  South, S M ^a   Wright, A W E ^a   Lau, M ^a   Mather, L E ^a   Smith, M T ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; MORPHINE; MORPHINE 3 GLUCURONIDE; TESTOSTERONE; TESTOSTERONE ENANTATE;

ADOLESCENT; ANTINOCICEPTION; AREA UNDER THE CURVE; ARTICLE; CASTRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; ELECTROCHEMICAL DETECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOT PLATE TEST; MALE; MODULATION; MORPHINE TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CHLORAMPHENICOL; CREATININE; DRUG TOLERANCE; FEMALE; INFUSIONS, INTRAVENOUS; MALE; MORPHINE; MORPHINE DERIVATIVES; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 0035082618     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Administration of testosterone alleviates the constitutive sex difference in rat brain cytochrome P-450
2. Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: A microdialysis study
3. A receptor complex
4. Sex differences and endocrine regulation of morphine oxidation in rat liver
5. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats
6. Gender-related differences in the antinociceptive properties of morphine
7. Sex-related differences in morphine's antinociceptive activity: Relationship to serum and brain concentrations
8. Purification and properties of two rat liver phenobarbital-inducible UDP-glucuronosyltransferases that catalyze the glucuronidation of opioids
9. The enantioselective glucuronidation of morphine in rats and humans. Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme
10. Sex differences in development of morphine tolerance and dependence in the rat
11. Synthetic analgesics. II. Dithienylbutenyl and dithienylbutylamines
12. The disposition of morphine and its metabolites in the in situ rat isolated perfused liver
13. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?
14. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat
15. Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: An electrophysiological study
16. Interactions among aging, gender, and gonadectomy effects upon morphine antinociception in rats
17. Endocrine influences on the actions of morphine. IV. Effects of sex and strain
18. Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats
19. Gender effects and central opioid analgesia
20. Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity
21. The disposition of morphine and its 3-and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine
22. In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidation
23. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids
24. Gender differences in two forms of cold-water swim analgesia
25. Gender-specific and gonadectomy-specific effects upon swim analgesia: Role of steroid replacement therapy
26. Gender determinants of opioid mediation of swim analgesia in rats
27. Morphine-3-glucuronide: Evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat
28. The excitatory behavioral and antianalgesic pharmacology of normorphine-3-glucuronide (NM3G) after intracerebroventricular administration to rats
29. Systemic co-administration of chloramphenicol with intravenous but not intracerebroventricular morphine increases morphine antinociception and delays the development of antinociceptive tolerance in rats
30. Morphine-3-glucuronide: A potent antagonist of morphine analgesia
31. Sex hormones differentially regulate isoforms of UDP-glucuronosyltransferase
32. Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats
33. Characteristics of the gastrointestinal absorption of morphine in rats
34. Improved one-step solid-phase extraction method for morphine, morphine-3-glucuronide, and morphine-6-glucuronide from plasma and quantitation using high-performance liquid chromatography with electrochemical detection
35. High doses of spinal morphine produce a non-opiate receptor-mediated hyperesthesia: Clinical and theoretic implications